PLANT MOLECULAR PHARMING: THE FUTURE OF PHARMACEUTICAL BIOTECHNOLOGY
AbstractPlants are the natural sources of a vast diversity of molecules, exploited for the benefit of human health. They are the factories synthesizing proteins, carbohydrates, secondary metabolites, and biopolymers. Further, converting these molecules into antioxidants, pharmaceuticals, food, and biofuels is a major industrial process. Plants are becoming significant sources for producing pharmaceutically essential proteins, metabolites, vaccines, industry-based drugs, and bioplastics and are explored for large-scale production. Plant molecular pharming will enable the production of the desired therapeutic proteins. Plant-based pharmaceutical products are advantageous as they are free of vectors and pathogens utilized to transfer genes. Biopharming offers augmented breeding conditions, high biomass productivity, and excellent yield at low cost, making the plants an attractive platform for pharmaceutical production. The ability of plants to produce pharmaceutical-related products and the methodology involved in the production were discussed in this article. Technologies implemented for increased productivity of molecular pharming were also discussed, along with biopharma products, applications and limitations.
Article Information
7
4865-4870
485 KB
820
English
IJPSR
A. Venkata Sai Sanat and K. V. Chaitanya *
Department of Microbiology and Food Science Technology, GITAM Institute of Technology, GITAM University, Visakhapatnam, Andhra Pradesh, India.
viswanatha.chaitanya@gmail.com
17 March 2022
14 May 2022
02 June 2022
10.13040/IJPSR.0975-8232.13(12).4865-70
01 December 2022
Download